Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel

Table 4 T-test showing mean treatment duration (number of treatment cycles) for patients with or without thrombocytopenia reported

	No thrombocytopenia	Thrombocytopenia	t-value	p-value
Cycles (n)	3.4	6.3	−3.0	0.003
SD	1.79	4.52

ISSN: 1471-2407